H.R. 946 seeks to amend title XI of the Social Security Act to address the exclusion criteria for orphan drugs in the Drug Price Negotiation Program. It introduces changes to how the time elapsed since the approval of former orphan drugs is calculated, ensuring such drugs are...
Simple Explanation
H.R. 946 wants to make sure that special medicines called "orphan drugs," which are for rare diseases, are priced fairly and can help more than one rare disease. It also tries to explain things more clearly so everyone understands how these rules work.